{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:37:45Z","timestamp":1790019465470,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Bozok University Scientific Research Project Unit","award":["6602b-TF 18-198"],"award-info":[{"award-number":["6602b-TF 18-198"]}]},{"name":"Bozok University Microbiology Laboratory"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.imlet.2019.05.008","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T16:15:24Z","timestamp":1558455324000},"page":"28-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The polymorphism rs4696480 in the TLR2 gene is associated with psoriasis patients in the Turkish population"],"prefix":"10.1016","volume":"211","author":[{"given":"Seda","family":"Sabah -\u00d6zcan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclhan","family":"G\u00fcrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.imlet.2019.05.008_bib0005","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1600-0625.2007.00629.x","article-title":"Immunopathogenesis of psoriasis","volume":"16","author":"Sabat","year":"2007","journal-title":"Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.imlet.2019.05.008_bib0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/jamaophthalmol.2017.0569","article-title":"Risk of uveitis among people with psoriasis: a nationwide cohort study","volume":"135","author":"Chi","year":"2017","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.imlet.2019.05.008_bib0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2147\/DDDT.S32713","article-title":"New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast","volume":"7","author":"Palfreeman","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.imlet.2019.05.008_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdermsci.2013.08.014","article-title":"The association of polymorphisms of the vitamin D receptor gene with psoriasis in the Han population of northeastern China","volume":"73","author":"Zhou","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.imlet.2019.05.008_bib0025","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.imlet.2019.05.008_bib0030","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/jir.2012.0140","article-title":"Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer","volume":"33","author":"Medvedev","year":"2013","journal-title":"J. Interferon Cytokine Res."},{"issue":"3","key":"10.1016\/j.imlet.2019.05.008_bib0035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/jnr.21509","article-title":"Statins enhance toll-like receptor 4-mediated cytokine gene expression in astrocytes: implication of Rho proteins in negative feedback regulation","volume":"86","author":"Konat","year":"2008","journal-title":"J. Neurosci. Res."},{"issue":"2","key":"10.1016\/j.imlet.2019.05.008_bib0040","doi-asserted-by":"crossref","DOI":"10.4161\/onci.22945","article-title":"Links between Toll-like receptor 4 and breast cancer","volume":"2","author":"Ahmed","year":"2013","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.imlet.2019.05.008_bib0045","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1468-3083.2011.04372.x","article-title":"Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis","volume":"27","author":"Garcia-Rodriguez","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.imlet.2019.05.008_bib0050","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/exd.12383","article-title":"TLR2 and TLR4 expression in atopic dermatitis, contact dermatitis and psoriasis","volume":"23","author":"Panzer","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.imlet.2019.05.008_bib0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev.med.59.061206.112455","article-title":"The effect of toll-like receptors and toll-like receptor genetics in human disease","volume":"59","author":"Garantziotis","year":"2008","journal-title":"Annu. Rev. Med."},{"issue":"6","key":"10.1016\/j.imlet.2019.05.008_bib0060","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ni.2284","article-title":"Genetic variation in Toll-like receptors and disease susceptibility","volume":"13","author":"Netea","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2019.05.008_bib0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2012.00079","article-title":"The role of TLR2 in infection and immunity","volume":"3","author":"Oliveira-Nascimento","year":"2012","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2019.05.008_bib0070","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/jcmm.12963","article-title":"MicroRNA-181b negatively regulates the proliferation of human epidermal keratinocytes in psoriasis through targeting TLR4","volume":"21","author":"Feng","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.imlet.2019.05.008_bib0075","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/ced.13008","article-title":"Toll-like receptor (TLR)7 expression in mycosis fungoides and psoriasis: a case-control study","volume":"42","author":"El Tawdy","year":"2017","journal-title":"Clin. Exp. Dermatol."},{"issue":"7","key":"10.1016\/j.imlet.2019.05.008_bib0080","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00109-005-0677-x","article-title":"TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children","volume":"83","author":"Berdeli","year":"2005","journal-title":"J. Mol. Med."},{"issue":"20","key":"10.1016\/j.imlet.2019.05.008_bib0085","doi-asserted-by":"crossref","first-page":"e6822","DOI":"10.1097\/MD.0000000000006822","article-title":"Association of single-nucleotide polymorphisms in toll-like receptor 2 gene with asthma susceptibility: a meta-analysis","volume":"96","author":"Gao","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.imlet.2019.05.008_bib0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mgene.2016.04.001","article-title":"Association of TLR and TREM-1 gene polymorphisms with atherosclerosis severity in a Russian population","volume":"9","author":"Kutikhin","year":"2016","journal-title":"Meta Gene"},{"issue":"6","key":"10.1016\/j.imlet.2019.05.008_bib0095","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1744-313X.2007.00709.x","article-title":"Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children","volume":"34","author":"Tabel","year":"2007","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.imlet.2019.05.008_bib0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.archoralbio.2017.06.003","article-title":"Toll-like receptor 2 rs4696480 polymorphism and risk of oral cancer and oral potentially malignant disorder","volume":"82","author":"de Barros Gallo","year":"2017","journal-title":"Arch. Oral Biol."},{"issue":"3","key":"10.1016\/j.imlet.2019.05.008_bib0105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2249.2007.03428.x","article-title":"Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis","volume":"149","author":"Veltkamp","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2019.05.008_bib0110","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1365-2133.2005.06645.x","article-title":"Psoriasis: dysregulation of innate immunity","volume":"152","author":"Bos","year":"2005","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.imlet.2019.05.008_bib0115","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.clindermatol.2005.01.009","article-title":"Psoriasis: a fresh look","volume":"23","author":"Galadari","year":"2005","journal-title":"Clin. Dermatol."},{"issue":"3 Suppl 2","key":"10.1016\/j.imlet.2019.05.008_bib0120","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jaad.2005.10.057","article-title":"Innate and adaptive immunity and the pathophysiology of psoriasis","volume":"54","author":"Gaspari","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.imlet.2019.05.008_bib0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jdermsci.2016.04.014","article-title":"TLR2 and TLR4 polymorphisms in southern chinese psoriasis vulgaris patients","volume":"83","author":"Shi","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.imlet.2019.05.008_bib0130","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/sj.gene.6364337","article-title":"Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk","volume":"7","author":"Nieters","year":"2006","journal-title":"Genes Immun."},{"issue":"3","key":"10.1016\/j.imlet.2019.05.008_bib0135","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/tpj.2017.31","article-title":"Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis","volume":"18","author":"Loft","year":"2018","journal-title":"Pharmacogenomics J."},{"issue":"8","key":"10.1016\/j.imlet.2019.05.008_bib0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043124","article-title":"G.s. group, Toll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary disease","volume":"7","author":"Budulac","year":"2012","journal-title":"PLoS One"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247819301117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247819301117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T21:17:56Z","timestamp":1560201476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247819301117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":28,"alternative-id":["S0165247819301117"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2019.05.008","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The polymorphism rs4696480 in the TLR2 gene is associated with psoriasis patients in the Turkish population","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2019.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}